A nutrient mixture modulates ovarian ES-2 cancer progression by inhibiting xenograft tumor growth and cellular MMP secretion, migration and invasion

International Journal of Clinical and Experimental Medicine

Volumn 9, Issue 2, 2016, Pages 814-822

  Roomi, M Waheed ^a   Kalinovsky, Tatiana ^a   Rath, Matthias ^a   Niedzwiecki, Aleksandra ^a  

^a Dr Rath Research Institute   (United States)

Author keywords

Matrigel invasion; Migration; MMPs; Nutrients; Ovarian cancer ES 2 cell line; Tumor growth

Indexed keywords

ACETYLCYSTEINE; ARGININE; ASCORBIC ACID; COPPER; GELATINASE A; GREEN TEA EXTRACT; HERBACEOUS AGENT; LYSINE; MANGANESE; PROLINE; QUERCETIN; SELENIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OVARY CANCER; TUMOR XENOGRAFT; ZYMOGRAPHY;

EID: 84961755720     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. American Cancer Society. What are the key statistics about ovarian cancer? http://www.cancer.org/cancer/ovariancancer/detailedguide/ovarian-cancer-key-statistics Accessed 7/28/15. Last revised 3/12/15.
2. Ovarian Cancer Alliance: Ovarian Cancer. Statistics. http://www.ovariancancer.org/about/statistics/Accessed7/28/15.
3. Duffy MJ. The role of proteolytic enzymes in cancer invasion and metastasis. Clin Exp Metastasis 1992; 10: 145-155.
4. Davidson B, Goldberg I, Gotlieb WH, Kopoiovic J, Ben-Baruch G, Nesland JM, Berner A, Byrne M and Reich R. High levels of MMP-2, MMP-9, MT1-MMP and TIMP-2 mRNA correlate with poor survival in ovarian carcinoma. Clin Exp Metastasis 1999; 17: 799-808.
5. Davidson B, Goldberg I, Gotlieb WH, Kopoiovic J, Ben-Baruch G, Nesland JM and Reich R. The prognostic value of metalloproteinases and angiogenic factors in ovarian carcinoma. Mol Cell Endocrinol 2002; 187: 39-45.
6. Wu X, Li H, Kang L, Li L, Wang W and Shan B. Activated matrix metalloproteinase-2a potential maker of prognosis for epithelial ovarian cancer. Gynecol Oncol 2002; 84: 126-134.
7. Lopata A, Agresta F, Quinn MA, Smith C, Ostor AG and Salamonsen LA. Detection of endometrial cancer by determination of matrix metalloproteinases in the uterine cavity. Gynecol Oncol 2003; 90: 318-324.
8. Torng PL, Mao TL. Chan WY, Huang SC and Lin CT. Prognostic significance of stromal metalloproteinase-2 in ovarian adenocarcinoma and in relation to carcinoma progression. Gynecol Oncol 2004; 92: 559-567.
9. Rath M and Pauling L. Plasmin-induced proteolysis and the role of apoprotein (a), lysine and synthetic analogs. Orthomol Med 1992; 7: 17-23.
10. Niedzwiecki A, Roomi MW, Kalinovsky T and Rath M. Micronutrient synergy–a new tool in effective control of metastasis and other key mechanisms of cancer. Cancer Metastasis Rev 2010; 29: 529-543.
11. Roomi MW, Ivanov V, Kalinovsky T, Niedzwiecki A and Rath M. Inhibition of matrix metalloproteinase-2 and invasion of human ovarian cancer cell SK-OV-3 with lysine, proline, arginine, ascorbic acid and green tea extract. J Obstet Gynaecol Res 2006; 32: 148-154.
12. Aldercreutz H. Western diet and Western disease: some hormonal and biochemical mechanisms and associations. Scand J Clin Lab Invest Suppl 1990; 201: 3-23.
13. Miller AB. Diet and Cancer: A review. Acta Oncologica 1990; 29: 87-95.
14. Sun Z, Chen YH, Wang P, Zhang J, Gurewich V, Zhang P and Liu JN. The blockage of high-affinity lysine binding sites of plasminogen by EACA significantly inhibits prourokinase-induced plasminogen activation. Biochem Biophys Acta 2002; 1596: 182-192.
15. Kemberling JK, Hampton JA, Keck RW, Gomez MA and Selman SH. Inhibition of bladder tumor growth by the green tea derivative epigallocatechin-3-gallate. J Urol 2003; 170: 773-6.
16. Sato D and Matsushima M. Preventive effects of urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl)-nitrosamine in rat by green tea leaves. Int J Urol 2003; 10: 160-6.
17. Valcic S, Timmermann BN, Alberts DS, Wachter GA, Krutzsch M, Wymer J and Guillen JM. Inhibitory effect of six green tea catechins and caffeine on the growth of four selected human tumor cell lines. Anticancer Drugs 1996; 7: 461-8.
18. Mukhtar H and Ahmed N. Tea polyphenols: prevention of cancer and optimizing health. Am J Clin Nutr 2000; 71: 1698s-1702s.
19. Yang GY, Liao J, Kim K, Yurtow EJ and Yang CS. Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. Carcinogenesis 1998; 19: 611-616.
20. Taniguchi S, Fujiki H, Kobayashi H, Go H, Miyado K, Sadano H and Shimikawa R. Effect of (-) epigallocatechin gallate, the main constituent of green tea, on lung metastasis with mouse B16 melanoma cell lines. Cancer Lett 1992; 65: 51-54.
21. Hara Y. Green tea: Health Benefits and Applications, Marcel Dekker, New York, Basel: 2001.
22. Kawakami S, Kageyama Y, Fujii Y, Kihara K and Oshima H. Inhibitory effects of N-acetyl cysteine on invasion and MMP 9 production of T24 human bladder cancer cells. Anticancer Res 2001; 21: 213-219.
23. Morini M, Cai T, Aluigi MG, Noonan DM, Masiello L, De Floro S, D’Agostinin F, Albini A and Fassima G. The role of the thiol N-acetyl cysteine in the prevention of tumor invasion and angiogenesis. Int J Biol Markers 1999; 14: 268-271.
24. Yoon SO, Kim MM and Chung AS. Inhibitory effects of selenite on invasion of HT 1080 tumor cells. J Biol Chem 2001; 276: 20085-20092.
25. Naidu KA, Karl RC and Coppola D. Antiproliferative and proapoptotic effect of ascorbyl stearate in human pancreatic cancer cells: association with decreased expression of insulin-like growth factor 1 receptor. Dig Dis Sci 2003; 48: 230-237.
26. Anthony HM and Schorah CJ. Severe hypovitaminosis C in lung-cancer patients: The utilization of vitamin C in surgical repair and lymphocyte-related host resistance. Br J Cancer 1982; 46: 354-367.
27. Maramag C, Menon M, Balaji KC, Reddy PG and Laxmanan S. Effect of vitamin C on prostate cancer cells in vitro: effect on cell number, viability and DNA synthesis. Prostate 1997; 32: 188-95.
28. Koh WS, Lee SJ, Lee H, Park C, Park MH, Kim WS, Yoon SS, Park K, Hong SI, Chung MH and Park CH. Differential effects and transport kinetics of ascorbate derivatives in leukemic cell lines. Anticancer Res 1998; 8: 2487-2493.
29. Chen Q, Espey MG, Krishna MC, Mitchell JB, Corpe CP, Buettner GR, Shacter E and Levine M. Pharmacologic ascorbic acid concentrations selectively kill cancer cells: Action as a pro-drug to deliver hydrogen peroxide to tissues. PNAS 2005; 102: 13604-13609.
30. Nunez C, Ortiz de Apodaca Y and Ruiz A. Ascorbic acid in the plasma and blood cells of women with breast cancer. The effect of consumption of food with an elevated content of this vitamin. Nutr Hosp 1995; 10: 68-372.
31. Kurbacher CM, Wagner U, Kolster B, Andreotti PE, Krebs D and Bruckner HW. Ascorbic acid (vitamin C) improves the antineoplastic activity of doxorubicin, cisplatin and paclitaxel in human breast carcinoma cells in vitro. Cancer Lett 1996; 103: 183-189.
32. Cooke JP and Dzau VJ. Nitric oxide synthase: Role in the genesis of vascular disease. Annu Rev Med 1997; 48: 489-509.
33. Gibellini L, Pinti M, Nasi M, Montagna JP, De Blasi S, Roat E, Bertoncelli L, Cooper EI and Cossarizza A. Quercetin and cancer chemoprevention. Evid-Based Complement Alternat Med 2011; 2011: 591356.